Insider Transactions in Q3 2021 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$21,000
$21.14 P/Share
|
|
Sep 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Sep 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.34%
|
$100,000
$20.99 P/Share
|
|
Sep 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.31%
|
$5,000
$1.13 P/Share
|
|
Aug 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$20,000
$20.81 P/Share
|
|
Aug 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Jul 06
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$45,500
$26.58 P/Share
|
|
Jul 06
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+0.29%
|
$1,750
$1.68 P/Share
|
|
Jul 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.6%
|
$57,200
$26.45 P/Share
|
|
Jul 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.4%
|
$6,600
$3.29 P/Share
|